SCHEMBL5155174

SCHEMBL5155174

Cc1cc(C)c(-c2c3c(c(-c4c(C)cc(C)cc4C(C)(C)C)c(-c4c(C)cc(C)cc4C(C)(C)C)c2-c2c(C)cc(C)cc2C(C)(C)C)-c2ccccc2-3)c(C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CA2 P00918 1/20 0.41
POLB P06746 1/20 0.41
TYR P14679 1/20 0.41
PDK2 Q15119 1/20 0.41
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 2/20 0.34
CYP2A6 P11509 1/20 0.34
HSPA5 P11021 1/20 0.34
CYP2C19 P33261 3/20 0.33
CYP2C9 P11712 2/20 0.33
HIF1A Q16665 2/20 0.33
CYP2D6 P10635 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
LMNA P02545 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium SCHEMBL31260776 0.78 PDK2 (0.34) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL28215781 0.78 CA2 (0.41) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL5174545 0.77 ELANE (0.44) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL11301324 0.75 PDK2 (0.37) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL5154102 0.73 GABRA1 (0.35) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL1883326 0.72 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL4459255 0.72 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL7809388 0.70 TDP1 (0.47) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL28077434 0.69 TYR (0.48) ALDH1A1SMN1; SMN2CA2POLBTYR
SCHEMBL4265966 0.69 PDK2 (0.44) ALDH1A1SMN1; SMN2PDK2TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173614-A1 Polyether composition NIPPON SHOKUBAI CO., LTD. (JP) 2007-07-26 US disclosed
EP-1737913-A1 POLYETHER COMPOSITION Nippon Shokubai Co.,Ltd. (JP) 2007-01-03 EP disclosed
WO-2005085354-A1 POLYETHER COMPOSITION NIPPON SHOKUBAI CO., LTD. (JP) 2005-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173614-A1 Polyether composition PUF60, RPL37A, RPL30 ALDH1A1 4055/4885SMN1; SMN2 713/4885CA2 1384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.